Compare JJSF & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JJSF | ANIP |
|---|---|---|
| Founded | 1971 | 2001 |
| Country | United States | United States |
| Employees | 1800 | N/A |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 1995 | 1999 |
| Metric | JJSF | ANIP |
|---|---|---|
| Price | $84.86 | $71.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $140.00 | $110.00 |
| AVG Volume (30 Days) | 200.7K | ★ 394.7K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.67% | N/A |
| EPS Growth | N/A | ★ 419.23 |
| EPS | 1.99 | ★ 2.32 |
| Revenue | ★ $1,022,038,000.00 | $206,547,000.00 |
| Revenue This Year | $0.30 | $21.01 |
| Revenue Next Year | $1.70 | $17.59 |
| P/E Ratio | $43.35 | ★ $31.19 |
| Revenue Growth | N/A | ★ 2.47 |
| 52 Week Low | $68.87 | $70.15 |
| 52 Week High | $104.65 | $99.50 |
| Indicator | JJSF | ANIP |
|---|---|---|
| Relative Strength Index (RSI) | 50.23 | 38.45 |
| Support Level | $79.72 | $70.15 |
| Resistance Level | $88.12 | $83.43 |
| Average True Range (ATR) | 2.44 | 1.97 |
| MACD | -0.77 | -0.20 |
| Stochastic Oscillator | 16.64 | 10.72 |
J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.